Pomerantz LLP is investigating potential securities claims on behalf of Sunrun Inc. investors and advises affected shareholders to contact the firm to discuss possible representation. This March 3, 2026 notice was published alongside many other same‑day Pomerantz alerts, including an investigation into Novo Nordisk, which together point to coordinated outreach across several issuers.
Click a connection line between nodes to view confidence and evidence.